Author

Francesca Ferrara

St. Jude Children's Research HospitalORCID 0000-0002-4973-1520Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Francesca Ferrara1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:CUT&Tag· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Robert E. ThromiD· 2 shared Adeleye Oluwatosin AdeshakiniD· 1 shared Andrew N. Nemecek· 1 shared Anoop Murthy KavirayaniiD· 1 shared Anthony A. HighiD· 1 shared Ben YoungbloodiD· 1 shared Bradley T. Stevens· 1 shared Brian CoventryiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Robert E. ThromORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 29, 2026

Myogenic and neural transcriptional circuitry determines PAX3::FOXO1 driven initiation of rhabdomyosarcoma

Bradley T. Stevens, Yang Zhang, Matthew R. Garcia…·Mark E. Hatley

This study uses a PAX3::FOXO1 inducible model to show P3F initiates ARMS transformation but is not required for maintaining proliferation or transcriptional programs.

DOI 10.64898/2026.10.27.761987

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 22, 2026

Reprogramming CAR T-Cells with designed bioPROTACs

Vivek S. Peche, Sebastian Kenny, Tae Gun Kang…·Stephen M Gottschalk

This paper demonstrates that bioPROTACs can reprogram CAR T-cells by targeting DNMT3A, offering a tunable alternative to gene editing for enhancing T-cell function.

1 citation

humanexperimental assay

𝕏 PostBluesky